Inhibitors of fatty acid oxidation.
This review discusses inhibitors of fatty acid oxidation for which sites and mechanisms of inhibition are reasonably well understood. Included in this review are hypoglycin, an inhibitor of butyryl-CoA dehydrogenase (EC 1.3.99.2), 4-pentenoic acid, 2-bromooctanoic acid, and 4-bromocrotonic acid all of which inhibit mitochondrial thiolases (EC 2.3.1.9 and 2.3.1.16) as well as several inhibitors of carnitine palmitoyltransferase I (EC 2.3.1.21) as for example 2-tetradecylglycidic acid, 2-bromopalmitic acid and aminocarnitine. Most of these inhibitors of fatty acid oxidation have been shown to cause hypoglycemia in animals and some also cause hypoketonemia. The advantages and limitations of using these inhibitors in metabolic studies are discussed.
D015097:3-Mercaptopropionic Acid / Q000494:pharmacology; D000102:Acetyl-CoA C-Acyltransferase / Q000037:antagonists & inhibitors*; D000217:Acyltransferases / Q000037:antagonists & inhibitors*; D000818:Animals; D001622:Betaine / Q000031:analogs & derivatives / Q000494:pharmacology; D002264:Carboxylic Acids / Q000494:pharmacology; D002331:Carnitine; D002334:Carnitine O-Palmitoyltransferase / Q000037:antagonists & inhibitors*; D044943:Fatty Acid Desaturases / Q000037:antagonists & inhibitors*; D005227:Fatty Acids / Q000378:metabolism*; D007005:Hypoglycins / Q000494:pharmacology
D002264:Carboxylic Acids; D005227:Fatty Acids; D007005:Hypoglycins; C041757:hypoglycin; D001622:Betaine; C045761:emeriamine; D015097:3-Mercaptopropionic Acid; D044943:Fatty Acid Desaturases; D000217:Acyltransferases; D000102:Acetyl-CoA C-Acyltransferase; D002334:Carnitine O-Palmitoyltransferase; D002331:Carnitine